Arcus Biosciences (RCUS) Net Income towards Common Stockholders (QoQ) (2017 - 2026)
Arcus Biosciences (RCUS) Net Income towards Common Stockholders (QoQ) (2017 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Arcus Biosciences |
3.05 Bn |
2.23 Bn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
-20.75% |
| Dec 31, 2025 |
21.48% |
| Mar 31, 2025 |
-19.15% |
| Dec 31, 2024 |
-2.17% |
| Sep 30, 2024 |
1.08% |
| Jun 30, 2024 |
-2,225.00% |
| Mar 31, 2024 |
95.06% |
| Dec 31, 2023 |
-14.08% |
| Sep 30, 2023 |
5.33% |
| Jun 30, 2023 |
6.25% |
| Mar 31, 2023 |
-19.40% |
| Dec 31, 2022 |
-3.08% |
| Sep 30, 2022 |
2.99% |
| Jun 30, 2022 |
1.47% |
| Mar 31, 2022 |
-124.33% |
| Dec 31, 2021 |
458.50% |
| Sep 30, 2021 |
-2.64% |
| Jun 30, 2021 |
-4.65% |
| Mar 31, 2021 |
-39.62% |
| Dec 31, 2020 |
-2,953.73% |
